Asymptomatic individuals at genetic risk of haemochromatosis take appropriate steps to prevent disease related to iron overload

被引:9
作者
Allen, Katrina J. [1 ,3 ]
Nisselle, Amy E. [2 ]
Collins, Veronica R. [2 ]
Williamson, Robert [4 ]
Delatycki, Martin B. [2 ,3 ]
机构
[1] Murdoch Childrens Res Inst, Gut & Liver Res Grp, Melbourne, Vic, Australia
[2] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia
关键词
compliance; haemochromatosis; population; screening; venesection;
D O I
10.1111/j.1478-3231.2008.01661.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: If community screening for hereditary haemochromatosis is to be considered, compliance with preventative measures and absence of significant psychological morbidity must be demonstrated. Methods: Workplace screening for the HFE C282Y mutation and then clinical care for C282Y homozygotes was instituted. Data were collected on understanding of test results, perceived health status and anxiety for C282Y homozygotes compared with controls. Uptake of clinical care, compliance and response to treatment and changes in diet were monitored for up to 4 years for C282Y homozygotes. Results: After 11 307 individuals were screened, 40/47 (85%) newly identified C282Y homozygotes completed questionnaires 12 months after diagnosis compared with 79/126 (63%) of controls. Significantly more C282Y homozygotes correctly remembered their test result compared with controls (95 vs 51%, P < 0.0001). No significant difference in perceived health status was observed within or between the two groups at 12 months compared with baseline. Anxiety levels decreased significantly for C282Y homozygotes at 12 months compared with before testing (P < 0.05). Forty-five of the 47 (95.8%) C282Y homozygotes accessed clinical care for at least 12 months. All 22 participants requiring therapeutic venesection complied with treatment for at least 12 months (range 12 - 47 months). Conclusion: Individuals at a high genetic risk of developing haemochromatosis use clinical services appropriately, maintain their health and are not 'worried well'. Population genetic screening for haemochromatosis can be conducted in the work place in a way that is acceptable and beneficial to participants.
引用
收藏
页码:363 / 369
页数:7
相关论文
共 30 条
[1]   Screening for haemochromatosis - producing or preventing illness? [J].
Adams, PC .
LANCET, 2005, 366 (9482) :269-271
[2]   Should we genetically test everyone for haemochromatosis? [J].
Allen, K ;
Williamson, R .
JOURNAL OF MEDICAL ETHICS, 1999, 25 (02) :209-214
[3]   Screening for hereditary haemochromatosis should be implemented now [J].
Allen, K ;
Williamson, R .
BRITISH MEDICAL JOURNAL, 2000, 320 (7228) :183-184
[4]   Iron-overload-related disease in HFE hereditary hemochromatosis [J].
Allen, Katrina J. ;
Gurrin, Lyle C. ;
Constantine, Clare C. ;
Osborne, Nicholas J. ;
Delatycki, Martin B. ;
Nicoll, Amanda J. ;
McLaren, Christine E. ;
Bahlo, Melanie ;
Nisselle, Amy E. ;
Vulpe, Chris D. ;
Anderson, Gregory J. ;
Southey, Melissa C. ;
Giles, Graham G. ;
English, Dallas R. ;
Hopper, John L. ;
Olynyk, John K. ;
Powell, Lawrie W. ;
Gertig, Dorota M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (03) :221-230
[5]   Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study [J].
Anderson, Roger T. ;
Wenzel, Lari ;
Walker, Ann P. ;
Ruggiero, Andrea ;
Acton, Ronald T. ;
Hall, Mark A. ;
Tucker, Diane C. ;
Thomson, Elizabeth ;
Harrison, Barbara ;
Howe, Edmund, III ;
Holup, Joan ;
Leiendecker-Foster, Catherine ;
Power, Tara ;
Adams, Paul .
GENETICS IN MEDICINE, 2006, 8 (11) :681-687
[6]   Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA [J].
Beutler, E ;
Felitti, VJ ;
Koziol, JA ;
Ho, NJ ;
Gelbart, T .
LANCET, 2002, 359 (9302) :211-218
[7]   Hereditary hemochromatosis - Gene discovery and its implications for population-based screening [J].
Burke, W ;
Thomson, E ;
Khoury, MJ ;
McDonnell, SM ;
Press, N ;
Adams, PC ;
Barton, JC ;
Beutler, E ;
Brittenham, G ;
Buchanan, A ;
Clayton, EW ;
Cogswell, ME ;
Meslin, EM ;
Motulsky, AG ;
Powell, LW ;
Sigal, E ;
Wilfond, BS ;
Collins, FS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (02) :172-178
[8]   The significance of haemochromatosis gene mutations in the general population: implications for screening [J].
Burt, MJ ;
George, PM ;
Upton, JD ;
Collett, JA ;
Frampton, CMA ;
Chapman, TM ;
Walmsley, TA ;
Chapman, BA .
GUT, 1998, 43 (06) :830-836
[9]   Insurance agreement to facilitate genetic testing [J].
Delatycki, M ;
Allen, K ;
Williamson, R .
LANCET, 2002, 359 (9315) :1433-1433
[10]   Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis [J].
Delatycki, MB ;
Allen, KJ ;
Nisselle, AE ;
Collins, V ;
Metcalfe, S ;
du Sart, D ;
Halliday, J ;
Aitken, MA ;
Macciocca, I ;
Hill, V ;
Wakefield, A ;
Ritchie, A ;
Gason, AA ;
Nicoll, AJ ;
Powell, LW ;
Williamson, R .
LANCET, 2005, 366 (9482) :314-316